![🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)](https://cddf.org/wp-content/uploads/2024/07/Whitepaper-announcement-1080x675.jpg)
![🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)](https://cddf.org/wp-content/uploads/2024/07/Whitepaper-announcement-1080x675.jpg)
![🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-3-1080x459.jpg)
🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024
Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers: Update...![[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]](https://cddf.org/wp-content/uploads/2024/07/Capture-2-1080x675.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...![ACT EU: Materials from MSP AG Meeting – 4 July 2024](https://cddf.org/wp-content/uploads/2024/07/Capture-1.jpg)
ACT EU: Materials from MSP AG Meeting – 4 July 2024
Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform – European Union (europa.eu)![ACT EU: Faster Access to Clinical Trial Information in Europe](https://cddf.org/wp-content/uploads/2024/06/Capture-1-1080x337.jpg)